It’s my first time in a decade being invited to co lead a Motivational interviewing seminar! I’m super excited and I know all who attend will take something with them for their clinical practice. It’s a solid workshop!
“Not just fentanyl: Understanding the complexities of the unregulated opioid supply through results from a drug checking service in British Columbia, Canada” by Pablo Gonzalez-Nieto et al (2025) via @ijdrugpolicy…whats in your drug supply?
Link: https://t.co/USrGD9hye1
“The evidence for safer supply is not perfect, but in countries where deaths are escalating due to toxic unregulated drug supplies, governments need to take urgent action. This means… investing in safer supply interventions”
Our editorial in @bmj_latest
https://t.co/6q4ITwaRPA
Just shared with some of the teammates where I work. We need a guideline and order set that is adaptable to the changing drug supply and levels of tolerance! Data and knowledge translation!!!
In response to this thoughtful @CMAJ article on the usefulness of short-acting opioids to relieve withdrawal in acute care hospitals, we published a response letter sharing our approach:
https://t.co/ERCoCgf9vI
Our CEO Dr Alexander Caudarella officially starts Issues of Substance 2023 by welcoming over 800 delegates. We’re coming together at a national level so we can go home with inspiration, innovation and inclusion for our communities. #CCSAConference
Data suggests interventions focusing on inhibitory control processes may be effective in combating alcohol use risk in male adolescents but both inhibitory and reward-related processes are likely of relevance to alcohol use behaviors in female adolescents. https://t.co/reqcIb5MiR
@DavidJuurlink I may be wrong - long ago, US public health data had methadone responsible for more opiod deaths than any other prescribed opioid. a public health signal; reactionary response to help; still causing harm. We need better, nimble, nuanced action that can adapt as signals change
Exclusive: B.C. clinicians who prescribe pharmaceutical alternatives to illicit drugs (“safer supply”), and ppl w/ lived and living experience (PWLLE) have provided feedback to PHO Dr Bonnie Henry. I’ll summarize the main themes in this thread.
https://t.co/elqYrsfdKL
"the association between prevalence rates of young adult depression and cannabis use strengthened following recreational legalization in the U.S"
https://t.co/jCjIUZDt83
A new psychotherapy for #PTSD may reduce dropout & is as effective as current best treatments, in a study by @VA_PTSD_Info. Written Exposure Therapy has fewer sessions than other psychotherapies & had less dropout than Prolonged Exposure (12.5% v 35.6%). https://t.co/6PnE4mb45x
“Conceptualising retention in treatment with long-acting injectable buprenorphine (for opioid use disorder) as a journey: Findings from a longitudinal qualitative study” by Stephen Parkin, @Jo_S_Neale, & John Strang via @ijdrugpolicy.
Link: https://t.co/vjyvyxDad2
#DrugPolicy
"Among individuals with amphetamine-type stimulant use disorder, treatment with prescription psychostimulants may decrease amphetamine-type stimulant use and craving. While effect size is limited, it may increase with a higher dosage of medications."
https://t.co/FEepDieI58
Excited to premiere my new series “Surviving Addiction” at the Canadian Society of Addiction Medicine (@csam_smca) next Thursday October 19th!
Whether you’re the healthcare provider or the person living with addiction, we all have a story.
#SurvivingAddiction#ComingSoon
@hubermanlab Ethics of charging people so much money for a chance of having a child. How much does a fertility doc and the clinic make per case. Mental health burden on family that put their life expenses into the chance of a kid. What kind of drug coverage plans cover this.
Subject matter experts, consultants and people with lived or living experience collaborated in developing 4 new occupational clusters and their related performance management and interview tools. Explore resources for all 11 categories now:
https://t.co/rjsJ74XCZN
#competencies